{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:05Z","timestamp":1790095025530,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41433-025-04136-y","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:18:38Z","timestamp":1764659918000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of blood pressure stability in diabetic retinopathy development"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9392-2429","authenticated-orcid":false,"given":"Chin-Chih","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Na","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-154X","authenticated-orcid":false,"given":"Yi-Ting","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"4136_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diab Res Clin Pr. 2019;157:107843.","journal-title":"Diab Res Clin Pr"},{"key":"4136_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124\u201336.","journal-title":"Lancet"},{"key":"4136_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ceo.12696","volume":"44","author":"DS Ting","year":"2016","unstructured":"Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44:260\u201377.","journal-title":"Clin Exp Ophthalmol"},{"key":"4136_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2337\/dci17-0026","volume":"40","author":"IH de Boer","year":"2017","unstructured":"de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diab Care. 2017;40:1273\u201384.","journal-title":"Diab Care"},{"key":"4136_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1001\/archopht.122.11.1631","volume":"122","author":"DR Matthews","year":"2004","unstructured":"Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004;122:1631\u201340.","journal-title":"Arch Ophthalmol"},{"key":"4136_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580\u201391.","journal-title":"N Engl J Med"},{"key":"4136_CR7","doi-asserted-by":"crossref","unstructured":"Li YT, Wang Y, Hu XJ, Chen JH, Li YY, Zhong QY et al. Association between Systolic Blood Pressure and Diabetic Retinopathy in Both Hypertensive and Normotensive Patients with Type 2 Diabetes: Risk Factors and Healthcare Implications. Healthcare. 2021;9:580.","DOI":"10.3390\/healthcare9050580"},{"key":"4136_CR8","doi-asserted-by":"publisher","first-page":"e0229665","DOI":"10.1371\/journal.pone.0229665","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Quang ND, Banu R, Kumar H, Tham YC, Cheng CY, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020;15:e0229665.","journal-title":"PLoS One"},{"key":"4136_CR9","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.2337\/dc12-2392","volume":"36","author":"Y Liu","year":"2013","unstructured":"Liu Y, Wang M, Morris AD, Doney AS, Leese GP, Pearson ER, et al. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS. Diab Care. 2013;36:3979\u201384.","journal-title":"Diab Care"},{"key":"4136_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12020-013-0119-4","volume":"46","author":"M Porta","year":"2014","unstructured":"Porta M, Taulaigo AV. The changing role of the endocrinologist in the care of patients with diabetic retinopathy. Endocrine. 2014;46:199\u2013208.","journal-title":"Endocrine"},{"key":"4136_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jdiacomp.2014.05.008","volume":"28","author":"T Takao","year":"2014","unstructured":"Takao T, Matsuyama Y, Suka M, Yanagisawa H, Kikuchi M, Kawazu S. Time-to-effect relationships between systolic blood pressure and the risks of nephropathy and retinopathy in patients with type 2 diabetes. J Diab Complications. 2014;28:674\u20138.","journal-title":"J Diab Complications"},{"key":"4136_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1161\/CIRCULATIONAHA.113.002717","volume":"128","author":"J Hata","year":"2013","unstructured":"Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation. 2013;128:1325\u201334.","journal-title":"Circulation"},{"key":"4136_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2362.2011.02574.x","volume":"42","author":"YT Hsieh","year":"2012","unstructured":"Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5\u00b75-year prospective analysis. Eur J Clin Invest. 2012;42:245\u201353.","journal-title":"Eur J Clin Invest"},{"key":"4136_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4093\/dmj.2018.0108","volume":"43","author":"ZB Yu","year":"2019","unstructured":"Yu ZB, Li D, Chen XY, Zheng PW, Lin HB, Tang ML, et al. Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study. Diab Metab J. 2019;43:350\u201367.","journal-title":"Diab Metab J"},{"key":"4136_CR15","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.2337\/dc13-1544","volume":"37","author":"A Sandb\u00e6k","year":"2014","unstructured":"Sandb\u00e6k A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE, et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. Diab Care. 2014;37:2015\u201323.","journal-title":"Diab Care"},{"key":"4136_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3646342","volume":"2020","author":"CM Zhao","year":"2020","unstructured":"Zhao CM, Cui XL, Wan G, Lu YZ, Niu YQ, Su CY, et al. Analysis of the Effect of Nine Consecutive Years\u2019 Intensive Management and Number of Times Achieving the Target Control on Endpoint Events in T2DM Patients in Sanlitun Community Health Service Center in Beijing. Int J Endocrinol. 2020;2020:3646342.","journal-title":"Int J Endocrinol"},{"key":"4136_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1447-0594.2011.00821.x","volume":"12","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Iimuro S, Ohashi Y, Sone H, Yamashita H, Ito H. Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus. Geriatr Gerontol Int. 2012;12:134\u201340.","journal-title":"Geriatr Gerontol Int"},{"key":"4136_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010627","volume":"8","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Fujihara K, Ishizawa M, Osawa T, Kaneko M, Ishiguro H, et al. Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus. J Am Heart Assoc. 2019;8:e010627.","journal-title":"J Am Heart Assoc"},{"key":"4136_CR19","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","volume":"114","author":"MC Leske","year":"2007","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965\u201372.","journal-title":"Ophthalmology"},{"key":"4136_CR20","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s00125-011-2253-y","volume":"54","author":"R Doerr","year":"2011","unstructured":"Doerr R, Hoffmann U, Otter W, Heinemann L, Hunger-Battefeld W, Kulzer B, et al. Oral glucose tolerance test and HbA(1)c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. Diabetologia. 2011;54:2923\u201330.","journal-title":"Diabetologia"},{"key":"4136_CR21","volume":"2010","author":"P Ruggenenti","year":"2010","unstructured":"Ruggenenti P, Iliev I, Filipponi M, Tadini S, Perna A, Ganeva M, et al. Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial. J Ophthalmol. 2010;2010:106384.","journal-title":"J Ophthalmol"},{"key":"4136_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","volume":"61","author":"RW Schrier","year":"2002","unstructured":"Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086\u201397.","journal-title":"Kidney Int"},{"key":"4136_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0895-7061(01)02281-6","volume":"15","author":"ST Knudsen","year":"2002","unstructured":"Knudsen ST, Poulsen PL, Hansen KW, Ebbeh\u00f8j E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens. 2002;15:244\u201350.","journal-title":"Am J Hypertens"},{"key":"4136_CR24","volume":"2022","author":"Q Lou","year":"2022","unstructured":"Lou Q, Chen X, Wang K, Liu H, Zhang Z, Lee Y. The Impact of Systolic Blood Pressure, Pulse Pressure, and Their Variability on Diabetes Retinopathy among Patients with Type 2 Diabetes. J Diab Res. 2022;2022:7876786.","journal-title":"J Diab Res"},{"key":"4136_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895\u2013905.","journal-title":"Lancet"},{"key":"4136_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.diabres.2017.03.027","volume":"128","author":"T Takao","year":"2017","unstructured":"Takao T, Suka M, Yanagisawa H, Matsuyama Y, Iwamoto Y. Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes. Diab Res Clin Pr. 2017;128:15\u201323.","journal-title":"Diab Res Clin Pr"},{"key":"4136_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jdiacomp.2016.09.003","volume":"31","author":"MW Sohn","year":"2017","unstructured":"Sohn MW, Epstein N, Huang ES, Huo Z, Emanuele N, Stukenborg G, et al. Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes. J Diab Complications. 2017;31:195\u2013201.","journal-title":"J Diab Complications"},{"key":"4136_CR28","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0895-7061(97)00277-X","volume":"10","author":"Y Imai","year":"1997","unstructured":"Imai Y, Aihara A, Ohkubo T, Nagai K, Tsuji I, Minami N, et al. Factors that affect blood pressure variability. A community-based study in Ohasama, Japan. Am J Hypertens. 1997;10:1281\u20139.","journal-title":"Am J Hypertens"},{"key":"4136_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.hco.0000240587.14463.58","volume":"21","author":"DF Su","year":"2006","unstructured":"Su DF. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies. Curr Opin Cardiol. 2006;21:486\u201391.","journal-title":"Curr Opin Cardiol"},{"key":"4136_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480\u20137.","journal-title":"N Engl J Med"},{"key":"4136_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4093\/dmj.2018.0182","volume":"42","author":"S Kusuhara","year":"2018","unstructured":"Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of Diabetic Retinopathy: The Old and the New. Diab Metab J. 2018;42:364\u201376.","journal-title":"Diab Metab J"},{"key":"4136_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1742-1241.2010.02552.x","volume":"65","author":"AK Sj\u00f8lie","year":"2011","unstructured":"Sj\u00f8lie AK, Dodson P, Hobbs FR. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int J Clin Pr. 2011;65:148\u201353.","journal-title":"Int J Clin Pr"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04136-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:37:44Z","timestamp":1769168264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4136"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04136-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}